litlas
Log inCreate account

J. Armstrong

Active 1966–2025

Also published as
J Armstrong
46
Papers
18,999
Citations
36
h-index
40
i10-index

Citations

Citations per year for J. Armstrong1966: 3 citations1967: 11 citations1968: 7 citations1969: 5 citations1970: 4 citations1971: 4 citations1972: 5 citations1973: 3 citations1974: 3 citations1975: 3 citations1976: 5 citations1977: 2 citations1978: 1 citations1979: 4 citations1980: 1 citations1981: 1 citations1983: 3 citations1984: 3 citations1985: 2 citations1986: 2 citations1987: 1 citations1988: 3 citations1989: 3 citations1990: 6 citations1991: 13 citations1992: 12 citations1993: 5 citations1994: 13 citations1995: 11 citations1996: 11 citations1997: 18 citations1998: 13 citations1999: 44 citations2000: 35 citations2001: 20 citations2002: 35 citations2003: 45 citations2004: 40 citations2005: 70 citations2006: 73 citations2007: 65 citations2008: 72 citations2009: 52 citations2010: 61 citations2011: 61 citations2012: 59 citations2013: 62 citations2014: 54 citations2015: 46 citations2016: 69 citations2017: 81 citations2018: 101 citations2019: 251 citations2020: 382 citations2021: 426 citations2022: 406 citations2023: 276 citations2024: 381 citations2025: 234 citations2026: 12 citations1982: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,408 citing papers, 25.7% of this breakdownChina: 545 citing papers, 10% of this breakdownUnited Kingdom: 353 citing papers, 6.4% of this breakdownItaly: 315 citing papers, 5.8% of this breakdownGermany: 242 citing papers, 4.4% of this breakdownSpain: 208 citing papers, 3.8% of this breakdownFrance: 190 citing papers, 3.5% of this breakdownAustralia: 163 citing papers, 3% of this breakdownCanada: 163 citing papers, 3% of this breakdownJapan: 161 citing papers, 2.9% of this breakdownNetherlands: 143 citing papers, 2.6% of this breakdownSouth Korea: 101 citing papers, 1.8% of this breakdown
0%25.7%Other 27.1%

Institutions

Fields

  • Medicine48.5%
  • Biochemistry, Genetics and Molecular Biology12.9%
  • Economics, Econometrics and Finance9.1%
  • Social Sciences7.6%
  • Business, Management and Accounting7.5%
  • Computer Science3.2%
  • Other11.2%

Topics

  • Lung Cancer Research Studies7.3%
  • Cancer Immunotherapy and Biomarkers5.9%
  • Lung Cancer Treatments and Mutations3.1%
  • Neuroendocrine Tumor Research Advances2.9%
  • Antibiotic Resistance in Bacteria2.9%
  • Antibiotics Pharmacokinetics and Efficacy2.3%
  • Other75.6%

Coauthors

All papers

Open in search
  1. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

    Authors: Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Dmytro Trukhin, Galina Statsenko, Maximilian J. Hochmair, Mustafa Özgüroğlu, Jun Ho Ji, Олександр Войтко, Artem Poltoratskiy, Santiago Ponce, Francesco Verderame, Libor Havel, Igor Bondarenko, Andrzej Każarnowicz, György Losonczy, Nikolay Conev, J. Armstrong, Natalie Byrne, Norah J. Shire, Haiyi Jiang, Jonathan W. Goldman, Emilio Batagelj, Ignacio Casarini, Anea Viviana Pastor, S. Sena, Juan José Zarbá, Otto C. Burghuber, Sylvia Hartl, Maximilian J. Hochmair, Bernd Lamprecht, Michael Studnicka, Luís Alberto Schlittler, Fabrício Augusto Martinelli de Oliveira, Aknar Calabrich, Gustavo Girotto, Peo Dos Reis, Carlos Fausto Nino Gorini, Peo Rafael Martins De Marchi, Clarissa Baldotto, Cláudia Vaz de Melo Sette, Mauro Zukin, Nikolay Conev, Assen Dudov, Rumyana Ilieva, Krassimir Koynov, Rositsa Krasteva, Ivan Tonev, Spartak Valev, Violetka Venkova, Minghong Bi, Chengshui Chen, Yuan Chen, Zhendong Chen, Jian Fang, Jifeng Feng, Zhigang Han, Jie Hu, Yi Hu, Xing Li, Zongan Liang, Lin Zhong, Rui Ma, Shenglin Ma, Kejun Nan, Yongqian Shu, Kai Wang, Mengzhao Wang, Gang Wu, Nong Yang, Zhixiong Yang, Helong Zhang, Wei Zhang, Jun Zhao, Yanqiu Zhao, Caicun Zhou, Jianying Zhou, Xiangdong Zhou, Libor Havel, Vı́tězslav Kolek, Leona Koubková, Jaromı́r Roubec, Jana Skřičková, Milada Zemanová, C. Chouaïd, Werner Hilgers, H. Léna, Denis Moro‐Sibilot, G. Robinet, Pierre-Jean Souquet, Jürgen Alt, Helge Bischoff, Christian Grohé, Eckart Laack, Susanne Lang, Jens Panse, Niels Reinmuth, Christian Schulz and 146 more - The Lancet 2019 cited by 2,199

  2. Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

    Authors: Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Dmytro Trukhin, Galina Statsenko, Maximilian J. Hochmair, Mustafa Özgüroğlu, Jun Ho Ji, Marina Chiara Garassino, Олександр Войтко, Artem Poltoratskiy, Santiago Ponce, Francesco Verderame, Libor Havel, Igor Bondarenko, Andrzej Każarnowicz, György Losonczy, Nikolay Conev, J. Armstrong, Natalie Byrne, Piruntha Thiyagarajah, Haiyi Jiang, Luis Paz‐Ares, Mikhail Dvorkin, Dmytro Trukhin, Galina Statsenko, Nataliia Voitko, Artem Poltoratskiy, Igor Bondarenko, Yuanbin Chen, Andrzej Każarnowicz, Luis Paz‐Ares, Mustafa Özgüroğlu, Nikolay Conev, Maximilian J. Hochmair, Otto C. Burghuber, Libor Havel, İrfan Çiçin, György Losonczy, В. Моисеенко, Mustafa Erman, Dariusz M. Kowalski, Marek Z. Wojtukiewicz, Hryhoriy Adamchuk, Alexander Vasilyev, Serhii Shevnia, Spartak Valev, Niels Reinmuth, Jun Ho Ji, Maria Amelia Insa Molla, Grygorii Ursol, Anne C. Chiang, Sylvia Hartl, Zsolt Horváth, Gábor Pajkos, Francesco Verderame, Katsuyuki Hotta, Sang‐We Kim, Alexey Smolin, Tuncay Göksel, Shaker R. Dakhil, Jaromı́r Roubec, Krisztina Bogos, Marina Chiara Garassino, Robin Cornelissen, Jong-Seok Lee, M.R. García Campelo, Marta López Brea, Ahmet Alacacıoğlu, Ignacio Casarini, Rumyana Ilieva, Ivan Tonev, A Somfay, Jair Bar, Alona Zer Kuch, Mauro Minelli, Roberta Bartolucci, Fausto Roila, Haruhiro Saito, Koichi Azuma, Gyeong‐Won Lee, Alexander Luft, Michal Urda, Juan Ignacio Delgado Mingorance, M. Majem Tarruella, David R. Spigel, Krassimir Koynov, Milada Zemanová, Jens Panse, Christian Schulz, Zsolt Pápai Székely, Veronika Sárosi, Angelo Delmonte, Anna Bettini, Makoto Nishio, Isamu Okamoto, Lizza Hendriks, Sławomir Mańdziuk and 153 more - The Lancet Oncology 2020 cited by 687

  3. Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer

    Authors: Thomas Powles, James W.F. Catto, Matthew D. Galsky, Hikmat Al‐Ahmadie, Joshua J. Meeks, Hiroyuki Nishiyama, Toan Quang Vu, Lorenzo Antonuzzo, Paweł Wiechno, Vagif Atduev, Ariel Galapo Kann, Tae‐Hwan Kim, Cristina Suárez, Chao-Hsiang Chang, Florian Roghmann, Mustafa Özgüroğlu, Bernhard J. Eigl, Niara Oliveira, Tomáš Büchler, Moran Gadot, Yousef Zakharia, J. Armstrong, Ashok Kumar Gupta, Stephan Hois, Michiel S. van der Heijden - New England Journal of Medicine 2024 cited by 322

  4. Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC

    Authors: Lillian L. Siu, Caroline Even, Ricard Mesı́a, Éva Remenár, Amaury Daste, Jean‐Pierre Delord, Jürgen Krauß, Nabil F. Saba, Lisle M. Nabell, Neal Ready, Irene Braña, Nuria Kotecki, Dan P. Zandberg, Jill Gilbert, Hisham Mehanna, Marcelo Bonomi, Anthony Jarkowski, Giovanni Melillo, J. Armstrong, Sophie Wildsmith, Jérôme Fayette - JAMA Oncology 2018 cited by 310

  5. Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy

    Authors: Dan P. Zandberg, Alain P. Algazi, Antonio Jimeno, James Good, Jérôme Fayette, Nathaniel Bouganim, Neal Ready, Paul Clement, Caroline Even, Raymond Jang, Stuart J. Wong, Ulrich Keilholz, Jill Gilbert, Moon J. Fenton, Irene Braña, Stéphanie Henry, Éva Remenár, Zsuzsanna Pápai, Lillian L. Siu, Anthony Jarkowski, J. Armstrong, Kobby Asubonteng, Jean Fan, Giovanni Melillo, Ricard Mesı́a - European Journal of Cancer 2018 cited by 267

  6. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study

    Authors: Yehuda Carmeli, J. Armstrong, Peter J. Laud, Paul Newell, Greg Stone, Angela Wardman, Leanne B. Gasink - The Lancet Infectious Diseases 2016 cited by 409

  7. Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program

    Authors: Flo ri an Wagenlehner, Jack D. Sobel, Paul Newell, J. Armstrong, Xiangning Huang, Gregory G. Stone, Katrina Yates, Leanne B. Gasink - Clinical Infectious Diseases 2016 cited by 352

  8. Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

    Authors: John E. Mazuski, Leanne B. Gasink, J. Armstrong, Helen Broadhurst, Greg Stone, Douglas R. Rank, Lily Llorens, Paul Newell, Jan Pachl - Clinical Infectious Diseases 2016 cited by 385

  9. Journal of economic literature

    Authors: J. Armstrong - International Journal of Forecasting 1996 cited by 9,981

  10. Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimens

    Authors: David P. Nicolau, Leonard Siew, J. Armstrong, James Li, Timi Edeki, Maria Learoyd, Shampa Das - Journal of Antimicrobial Chemotherapy 2015 cited by 129

  11. Retinal Precursors and the Development of Geographic Atrophy in Age-Related Macular Degeneration

    Authors: Michael L. Klein, Frederick L. Ferris, J. Armstrong, Thomas S. Hwang, Emily Y. Chew, Susan B. Bressler, Suresh R. Chandra - Ophthalmology 2007 cited by 224

  12. Methods and Reproducibility of Grading Optimized Digital Color Fundus Photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2)

    Authors: Ronald P. Danis, Amitha Domalpally, Emily Y. Chew, Traci E. Clemons, J. Armstrong, John Paul SanGiovanni, Frederick L. Ferris - Investigative Ophthalmology & Visual Science 2013 cited by 122

  13. Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder

    Authors: Graeme Suthers, J Armstrong, J McCormack, D Trott - Journal of Medical Genetics 2005 cited by 181

  14. Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study

    Authors: Jonathan I. Silverberg, Andreas Pinter, Afsáneh Alavi, Charles Lynde, Jean‐David Bouaziz, Andreas Wollenberg, Dédée F. Murrell, Sady Alpizar, Vivian Laquer, Kamel Chaouche, Faiz Ahmad, J. Armstrong, Christophe Piketty - Journal of the European Academy of Dermatology and Venereology 2021 cited by 59

  15. Intel 4 CMOS Technology Featuring Advanced FinFET Transistors optimized for High Density and High-Performance Computing

    Authors: Bernhard Sell, S. An, J. Armstrong, D. Bahr, B. Bains, Rohan Bambery, K. Bang, D. Basu, S. Bendapudi, D. Bergstrom, R. Bhandavat, S. Bhowmick, M. Buehler, D. Caselli, S. Cekli, Vrsk. Chaganti, Y. J. Chang, K. Chikkadi, T. Chu, T. Crimmins, G. Darby, C. Ege, P. Elfick, Tyler Elko-Hansen, S. Fang, C. Gaddam, M. Ghoneim, H. Gomez, S. Govindaraju, Z. Guo, Walid M. Hafez, M. Haran, M. Hattendorf, S. Hu, A. Jain, S. Jaloviar, M. Jang, J. Kameswaran, V. Kapinus, A. Kennedy, S. Klopcic, D. Krishnan, J. Leib, Y.-T. Lin, N. Lindert, G. Liu, O. Loh, Y. Luo, S. Mani, M. Mleczko, S. Mocherla, P. Packan, M. Paik, A. Paliwal, R. Pandey, K. Patankar, L. Pipes, P. Plekhanov, Chetan Prasad, M. Prince, G. Ramalingam, R. Ramaswamy, J. Riley, J. R. Sanchez Perez, Justin Sandford, A. Sathe, Faisal Ahmed Shah, H. Shim, S. Subramanian, S. Tandon, M. Tanniru, D. Thakurta, T. Troeger, X. Wang, C. Ward, A. Welsh, S. Wickramaratne, J. Wnuk, S. Q. Xu, P. Yashar, J. Yaung, K. Yoon, N. Young - IEEE Symposium on VLSI Technology and Circuits (VLSI Technology and Circuits) 2022 cited by 43

  16. A Multi-Institutional Study Evaluating the Diagnostic Utility of the Spec cPL™ and SNAP® cPL™ in Clinical Acute Pancreatitis in 84 Dogs

    Authors: K McCord, Paul S. Morley, J. Armstrong, Kenneth W. Simpson, Mark Rishniw, Marnin Forman, David S. Biller, Nicolas Parnell, Katharine Arnell, Steve L. Hill, Sophia Avgeris, Howard Gittelman, Mackenzie Moore, Mary Hitt, Gretchen Oswald, Stanley L. Marks, Derek P. Burney, David C. Twedt - Journal of Veterinary Internal Medicine 2012 cited by 114

  17. Novel Combinations of Immunotherapies or DNA Damage Repair Inhibitors in Platinum-Refractory Extensive-Stage Small Cell Lung Cancer: The Phase II BALTIC Study

    Authors: Niels Reinmuth, Óscar Juan, Dariusz M. Kowalski, Maciej Bryl, Anna Kryzhanivska, David Vicente, Zsolt Horváth, Gabriella Gálffy, Eszter Csánky, Zsolt Pápai Székely, Ihor Vynnychenko, J. Armstrong, Tapashi Dalvi, Mingchao Xie, Sonia Iyer, Yashaswi Shrestha, Haiyi Jiang, Igor Bondarenko - Clinical Cancer Research 2024 cited by 8

  18. Purification and Properties of Human Erythrocyte Carbonic Anhydrases

    Authors: J Armstrong, Dirck V. Myers, Jacob A. Verpoorte, John T. Edsall - Journal of Biological Chemistry 1966 cited by 539

  19. A Consensus-based Educational Framework and Competency Set for the Discipline of Disaster Medicine and Public Health Preparedness

    Authors: Italo Subbarao, James M. Lyznicki, Edbert B. Hsu, Kristine M. Gebbie, David Markenson, Barbara Barzansky, J. Armstrong, Emmanuel G. Cassimatis, Philip Coule, Cham E. Dallas, Richard V. King, Lewis Rubinson, Richard W. Sattin, Raymond E. Swienton, Scott R. Lillibridge, Frederick M. Burkle, Richard B. Schwartz, James J. James - Disaster Medicine and Public Health Preparedness 2008 cited by 215

  20. A Review of Staggered Array Pin Fin Heat Transfer for Turbine Cooling Applications

    Authors: J. Armstrong, D. Winstanley - Journal of Turbomachinery 1988 cited by 223

  21. A randomized, multicenter phase 3 study of durvalumab (D) and tremelimumab (T) as first-line treatment in patients with unresectable hepatocellular carcinoma (HCC): HIMALAYA study.

    Authors: Ghassan K. Abou‐Alfa, Stephen L. Chan, Junji Furuse, Peter R. Galle, Robin Kate Kelley, Shukui Qin, J. Armstrong, Annie Darilay, Gordana Vlahovic, Alejandra Negro, Bruno Sangro - Journal of Clinical Oncology 2018 cited by 92

  22. The GALAH Survey: Data Release 4

    Authors: Sven Buder, J. Kos, Ella Xi Wang, Madeleine McKenzie, Michael D. Howell, Sarah L. Martell, Michael Hayden, D. B. Zucker, Thomas Nordlander, B. T. Montet, G. Traven, Joss Bland‐Hawthorn, G. M. De Silva, K. C. Freeman, Graceanna Lewis, K. Lind, S. Sharma, Jeffrey D. Simpson, Dennis Stello, T. Zwitter, A. M. Amarsi, J. Armstrong, Kirsten Banks, M. A. Beavis, Kevin-Luke Beeson, Bin Chen, Ioana Ciucă, G. S. Da Costa, Richard de Grijs, Barbara B. Martin, David M. Nataf, Melissa Ness, Adam D. Rains, Tim Scarr, R. Vogrinčič, Zhujun Wang, Robert A. Wittenmyer, Yang Xie, the GALAH collaboration - arXiv (Cornell University) 2024 cited by 11

  23. Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer

    Authors: David G. McLeod, Peter Iversen, William A. See, Thomas Morris, J. Armstrong, Manfred P. Wirth, the Casodex Early Prostate Cancer Trialists’ Group - British Journal of Urology 2005 cited by 279

  24. A comparison between the GlideScope ® Video Laryngoscope and direct laryngoscope in paediatric patients with difficult airways – a pilot study

    Authors: C. Karsli, J. Armstrong, Jubal John - Anaesthesia 2010 cited by 92